Insight Molecular Diagnostics Inc. Increase Decrease In Operating Lease Liability
Insight Molecular Diagnostics Inc. (IMDX) reported Increase Decrease In Operating Lease Liability of -$167.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$84.00K.
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$83.00K.
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$20.00K.
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$57.00K.
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for fiscal 2025 was -$142.00K.
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for fiscal 2024 was -$291.00K.
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for fiscal 2023 was -$107.00K.
- Insight Molecular Diagnostics Inc. increase decrease in operating lease liability for fiscal 2022 was -$116.00K, a 178.91% decline from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$167.00K 10-Q · filed 2026-08-10 | -$187.00K derived: sum of 3 quarters · filed 2026-08-10 | -$244.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$83.00K 10-Q · filed 2026-05-13 | -$103.00K derived: sum of 2 quarters · filed 2026-05-13 | -$160.00K derived: sum of 3 quarters · filed 2026-05-13 | -$195.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$77.00K derived: sum of 2 quarters · filed 2026-03-26 | -$112.00K derived: sum of 3 quarters · filed 2026-08-10 | -$142.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$92.00K derived: sum of 2 quarters · filed 2026-08-10 | -$122.00K 10-Q · filed 2025-11-10 | -$290.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$65.00K 10-Q · filed 2026-08-10 | -$233.00K derived: sum of 3 quarters · filed 2026-08-10 | -$233.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$30.00K 10-Q · filed 2026-05-13 | -$198.00K derived: sum of 2 quarters · filed 2026-05-13 | -$198.00K derived: sum of 3 quarters · filed 2026-05-13 | -$225.00K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$168.00K derived: sum of 2 quarters · filed 2026-03-26 | -$195.00K derived: sum of 3 quarters · filed 2026-03-26 | -$291.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$27.00K derived: sum of 2 quarters · filed 2025-11-10 | -$123.00K 10-Q · filed 2025-11-10 | -$187.00K derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$123.00K 10-Q · filed 2025-08-11 | -$187.00K derived: sum of 3 quarters · filed 2025-08-11 | -$112.00K derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$96.00K 10-Q · filed 2025-05-12 | -$160.00K derived: sum of 2 quarters · filed 2025-05-12 | -$85.00K derived: sum of 3 quarters · filed 2025-05-12 | -$170.00K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $11.00K derived: sum of 2 quarters · filed 2025-03-24 | -$74.00K derived: sum of 3 quarters · filed 2025-03-24 | -$107.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.00K derived: sum of 2 quarters · filed 2024-11-12 | -$43.00K 10-Q · filed 2024-11-12 | -$3.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$118.00K 10-Q · filed 2024-08-08 | -$78.00K derived: sum of 3 quarters · filed 2024-08-08 | -$184.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$33.00K 10-Q · filed 2024-05-15 | $7.00K derived: sum of 2 quarters · filed 2024-05-15 | -$99.00K derived: sum of 3 quarters · filed 2024-05-15 | -$114.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$66.00K derived: sum of 2 quarters · filed 2024-04-16 | -$81.00K derived: sum of 3 quarters · filed 2024-04-16 | -$116.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | -$106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$121.00K derived: sum of 2 quarters · filed 2023-11-09 | -$156.00K 10-Q · filed 2023-11-09 | -$178.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$50.00K 10-Q · filed 2023-08-10 | -$94.00K 10-Q · filed 2022-08-12 | -$72.00K derived: sum of 3 quarters · filed 2023-08-10 | -$121.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$35.00K 10-Q · filed 2023-05-15 | -$57.00K derived: sum of 2 quarters · filed 2023-05-15 | -$106.00K derived: sum of 3 quarters · filed 2023-05-15 | $87.00K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | -$71.00K derived: sum of 2 quarters · filed 2023-04-12 | $122.00K derived: sum of 3 quarters · filed 2023-04-12 | $147.00K 10-K · filed 2023-04-12 | |
| 2021-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $144.00K derived: sum of 2 quarters · filed 2022-11-10 | $169.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $218.00K 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $1.50M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |